Oppenheimer Asset Management Inc. Repligen Corp Transaction History
Oppenheimer Asset Management Inc.
- $8.4 Billion
- Q2 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Repligen Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 17,447 shares of RGEN stock, worth $2.52 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
17,447
Previous 19,684
11.36%
Holding current value
$2.52 Million
Previous $2.5 Million
13.34%
% of portfolio
0.03%
Previous 0.03%
Shares
29 transactions
Others Institutions Holding RGEN
# of Institutions
510Shares Held
59MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.09 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$955 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$734 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$277 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$235 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.02B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....